Akero Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2021 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Akero Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2023.
  • Akero Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -1.05 USD/shares, a 47.9% decline year-over-year.
  • Akero Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -3.79 USD/shares, a 64.8% decline year-over-year.
  • Akero Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -2.89 USD/shares, a 0.7% decline from 2022.
  • Akero Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.87 USD/shares, a 0.69% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3 $0 -0.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$3 +$0.02 +0.69% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$3 Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.